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Abstract
The chance of implant failure is the matter of great concern to implantologists. Hence, 
the extending knowledge on this inevitable phenomenon is clinically essential. Peri-
implantitis is one of the implant failure factors. The lesion is an inflammatory reaction 
recognized by the loss of implant-supporting bone and diagnosed based on clinical 
inflammatory symptoms (such as hyperplastic soft tissue, pus discharge, color change 
of peri-implant marginal tissues, and gradual bone loss). Adult chronic periodontitis is 
a type of differential diagnosis in that it has considerable commonalities. Implant failure 
may also be due to surgical trauma, micro motion, and overloading. Implant failure is 
due to the lack of osteointegration, which is generally identified by implant loose and 
radiologic radiolucency. The other phenomenon is “fracturing implant” identified by a 
progressive loss of marginal bone but with no remarkable looseness. In this paper, we will 
shortly investigate causes, and effects of implant failure, and applicable parameters of the 
process. The aim of this review is to summarize the etiology, and complications of the 
dental implant failure, and its related risk factors including systemic disease, periodontal 
disease, and environmental factors.
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Introduction
Building on modern researches and information of biological 
principles, the science of implantology is increasingly extending 
the connection between living tissues and artificial structures. 
Despite its favorable outcome, some cases of implant treatment 
failure are reported.[1]
According to some quantitative criteria, implant failure is 
defined as “implant efficiency decrease lower than acceptable 
level.” The definition embraces different clinical status: All 
tangible loose cases to the loss of implant’s adjacent bone to 
more than 0.2 mm after the first loading year[2] or bleeding depth 
more than 5 mm from probing depth.[3] The difference between 
“implant failure” and “fracturing implant” is important, clinically. 
“Implant failure” is due to lack of osseointegration, which is 
generally recognized by implant looseness and peri-fixtural 
radiolucency.[4] Failure procedure may be sometimes slow but 
continuous.[5] The condition is recognizable by progressive loss 
of marginal bone but with no remarkable looseness, so it is called 
“fracturing implant.”[4]
Implant Complications and Failure
Implant complications and failure are thoroughly discussed 
in a review article.[6] Three major etiologic factors (infection, 
improvement disorder, and overloading) were named as factors 
of implant failure and complication:
Infection: Bacterial infection which caused the implant failure 
can be occurred in any time period.[7] At present, some terms are 




The peri-implant disease is a general term used for 
elaborating inflammatory reactions in the soft tissue around 
the implant.[8] Peri-implant mucositis is used for describing 
reversible inflammatory responses in soft tissues around the 
implant. It seems that other complications of the soft tissues 
(mucositis, hyperplastic, fistula, and mucosal abscess) mainly 
have infectious causes.[9] Fistula and hyperplastic mucositis are 
often presented with the looseness of prosthesis components.[10] 
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An abscess can sometimes be developed by trapped food particles 
in the gap around the implant.[11] Peri-implantitis is defined as 
inflammatory response along with bone loose in the soft tissue 
around the implant.[4] Plaque-induced infection on exposed 
surface of biomaterials can be categorized as kind of peri-
implantitis.[12] According to a study,[12] peri-implantitis was 
considered as a site-specific infection, which has many common 
characteristics with adult chronic periodontitis.
Improvement disorder: It seems that the intensity of surgical 
trauma (lack of irrigation and excessive temperature), micro-
motion and some other topical, and systematic features of the 
host playing a significant role in the implant failure.[11]
Overloading: Implant failure overloading is a condition, in 
which the dropped load on the implant is more than bone strength 
capacity. Failures, which occur between abutment connection 
and prosthesis delivery (are probably due to inappropriate 
loading condition or prosthesis procedures) are pertinent to 
overloading.[5] Implant failure is also due to improper surgical 
techniques, weak bone structure, inappropriate prosthesis 
design, and traumatic loading conditions.[13]
Evaluative Parameters of Implant Failure
Since implants are different in terms of design, surgical technique, 
and loading condition, they should be investigated by various 
methods. The most prevalent diagnosis criteria for evaluation of 
implant failure are the followings:
Clinical infection symptoms
Infection is the most common complication arises within the 
course of improvement. It includes swell, fistula, pus discharge, 
early or late mucosal wound dehiscence. Early mucosal wound 
dehiscence not only causes infection but also can bring about 
the inappropriate design of flap or early establishment of the 
denture.[14]
Early or late occurrence of complication may result in major 
consequences because in early complication implant stabilizer 
agent or the so called bone healing process is interrupted. Late 
symptoms of progressive marginal infection can cause implant 
failure.[15]
Clinical symptoms of infection such as hyperplastic soft 
tissue, pus discharge, the color change of marginal peri-implant 
tissues, etc., are symptoms, which need an interruption. 
Infection symptoms (early or late) are not enough for defining 
implant precaution individually and should be investigated in 
line with other parameters such as radiographic alteration or 
looseness. In cases of absent of other parameters, however, the 
lack of treatment of clinical infection symptoms may bring about 
implant failure. In general, infection symptoms are rather an 
indicator of a complication than implant failure.
Tangible clinical looseness
Implant looseness is the main sign of treatment failure. 
Sometimes the clinical condition exists but there is no sign of 
bone alteration in radiography.[16]
Different kinds of recognized looseness are horizontal, 
vertical, and rotational.[17] The reverse torque test is suggested 
for recognition of loose implants[18] and further evaluation of 
horizontal mobility of periotest machine.[19]
Rotational mobility could be a sign of interruption in the 
level of connection between the bone and the implant, but 
horizontal and vertical mobility may be related to bone loss and 
the presence of soft tissue capsule.[9]
Radiographic failure sign
Radiography still remains as one of the main methods of 
implant failure identification. The quality of radiographs and the 
experience of the clinician are two critical factors for evaluating 
the condition of the implant in radiography.[16] Providing 
standard periapical radiographs is essential for identification 
of peri-implant radiolucencies or diagnosis of progressive loss 
of the marginal bone.[20] The face of peri-implant radiolucency 
indicates a lack of direct implant-bone connection and the 
probable loss of implant stability, while, in cases of increased 
marginal bone loss, the implant could be stable.
Microbiology of Peri-implantitis and Peri-mucositis 
and Comparison with Periodontitis
Oral biofilm is the first etiological factor in peri-implant mucositis 
known as the first encounter of the host defense, biofilm reflect 
a fight affecting the natural tooth condition. Initial adhesion of 
the bacteria to the implant could be variable concerning the type 
surface topography. Implants with uneven surfaces increase the 
risk of formation of bacterial colonies.[21,22] In general, positions 
with periodontitis and peri-implant inflammation include more 
gram-negative bacteria than healthy positions.[23] Types of 
bacteria, which are seen with healthy and failed implants are like 
those bacteria existing in healthy and corrupted teeth, however, 
there are some significant discrepancies.
Reported risk factors for surrounding mucositis and peri-
implant inflammation include the patient’s periodontitis 
record.[24] Possibly, in case that surrounding dental pathogens, 
which are existing in peri-implant pockets be the same as natural 
teeth pathogens, then the host response and deconstruction of 
adjacent soft and hard tissues would be the natural teeth.
Smoking
Peri-implant and implant failure risks and inflammation factors 
are numerous. These factors include systematic disease, genetic 
traits, habitual use of drugs or alcohol, smoking, periodontal 
disease, radiation therapy, diabetes, osteoporosis, dental plaque, 
lack of oral health.[25-27] Smoking and its relationship with 
periodontitis have been the subject of much interest among the 
related studies.[28,29] The fact that smoker patients have more 
periodontal injuries than non-smokers is well-documented. 
According to the results of a project conducted by Karbach 
et al.,[30] smoking is the most important factor information of 
dental inflammatory mucositis. By the increase of dental implant 
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cases and patients application for the spread of the implant, most 
dentists are wondering whether the placement of the implant in 
smokers could lead to a failed dental reconstruction or not.
Appropriate placement of the implant is crucial, especially 
when the alveolar ridge is thin. D’haese and De Bruyn[31] found 
a little bias between the place of implantation and the real 
placement of implant in smokers while the bias did not observe 
in non-smokers. These researchers surmised that since the 
mucosal tissues are thicker in smokers the stability of appropriate 
surgical guide or prosthesis investigation will decrease, and this 
could lead to a change in final placement of the implant.
The various research results have shown that making the 
decision to the place of implants in smokers might not be 
possible easily.[32-37] The best method for smokers is to follow a 
smoke cessation program, in a way that they quit smoking prior 
to the implant. Smoking has a negative effect on the implant in 
patients with machined surface implants, fixed prosthesis, no 
marginal bone, bone-implant interface, and interleukin-1 (IL-1) 
genotype. There is no consensus among dentists for dental 
implants in smokers. Smoke cessation program seems to be an 
ideal solution, but results are not that much satisfying. Dentists 
who perform implants for smokers should clearly explain the 
high probability of the implant failure in every individual.
Systematic Risk Factors
Diabetes
The relationship between diabetes and periodontitis has been 
studied abundantly.[38,39] Some of these studies illustrate a 
reciprocal connection that the general improvement of a disease 
may ameliorate other studies, as well. Hyperglycemia or high 
blood sugar condition in diabetes, unless assessed accurately 
could cause changes in the glycosylation of advanced products/
receivers at the end of the advanced glycation end products 
(AGE)/receptor for AGE and ligand receptor activator of 
nuclear factor-kB, and the osteoprotegerin and can lead to 
overall safety imbalance and cytokines, as well as cell stresses. 
By increase in tissue destruction, this imbalance could cause 
periodontal pathogenesis and impaired healing. It seems that 
there is dependent dosage relationship between periodontitis 
and diabetes intensity and evidences indicate that periodontitis 
control could improve diabetes.[38,40] Similarly, patients 
with controlled diabetes are more exposed to periodontitis 
diseases.[41,42]
Obesity/hyperlipidemia
Some studies suggest a positive correlation between obesity or 
hyperlipidemia and periodontitis,[43-45] especially because the 
overweight is considered a metabolic syndrome. Usually, there 
is a little information on how hyperlipidemia affects the implant 
failure or the peri-implant inflammations.
Impaired organ function
There are limited numbers of researches on the relationship 
between the implant failure and impaired organ function. 
Studies that concentrating on the implant success in patients 
with transplanted organ (such as heart and liver) found that 
the clinical parameters and performed radiographies of dental 
implants in these individuals shown no significant difference 
with that of healthy people.[46-48] Since these studies include 
patients with resultant immune deficiency of transplanted 
organ, more researches are required for determining the effect 
organ transplant failure on dental implant failure and/or implant 
inflammation.
Osteoporosis
Osteoporosis is the result of bone density loss and is regarded as 
a preventive factor for a dental implant. Considerable numbers 
of new studies were concentrated on treatment of osteoporosis 
with bisphosphonates. Latest articles indicated that there is no 
limitation for the implant in patients with osteoporosis.[49,50] 
According to a study, on 3224 performed implants for 746 
women aged 50 or above, the bone mineral density on sub-
group of 129 women with 646 implants with osteoporosis and 
with no osteoporosis indicated that in no cases the osteoporosis 
is considered as a potential risk for the implant failure.[51] In this 
paper, the risk of implant failure in smokers was 2.6 times more 
than that of non-smokers.
Hormonal disorder
Fu et al.[52] illustrated the effect of glucocorticosteroids, non-
steroidal anti-inflammatory drugs, and statins- on the implant 
treatment. In general, non-steroidal anti-inflammatory drugs 
have a harmful impact on bone connection to the implant and 
post implantation bone density while it seems that strains have 
a positive effect on bone formation. Several studies on animals 
investigated the topical application of growth hormones have 
shown a positive effect in bone formation, and bone density loss 
in low-level estrogen.[53-56] Moy et al.,[57] indicated that women 
aged 60-79 are more potential to the risk of implant failure than 
women aged 40 or younger. However, according to this study, 
post-menopausal women who receiving estrogen are 2.55 times 
more at the risk of implant failure than women in the same age 
with no hormonal treatment.
Medications
In addition to bisphosphonates, there seems that no other 
drug is directly related to the implant failure. According to 
another study investigating the implants in patients with 
hypothyroidism, a year after the first stage of implant placement 
bone loss and undesirable response of the soft tissue was evident, 
while increase in the risk of implant failure was not observed.[58] 
By studying animals and as can be seen by reducing radiography, 
administration of cyclosporine to rabbits was in relation with the 
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bone loss rate.[59] Further studies are required for determining 
the direct effects of drugs on the implant failure and peri-implant 
tissues.
Bisphosphonates
Usually, most patients consume bisphosphonates for treating 
osteoporosis or during cancer treatments. Osteonecrosis of 
the jaw is considered as a problem that might be seen in some 
patients consuming bisphosphonates.[60] Bisphosphonate-
related osteonecrosis of the jaw (BRONJ), which is also named 
bisphosphonate-induced osteonecrosis of the jaw could occur 
in patients using oral or intravenous bisphosphonates.[60] 
Dentoalveolar trauma, like dental extraction, could lead to BRONJ, 
seemingly.[60,61] Dental implant placement in patients under 
bisphosphonate treatment calls for accurate investigation. 
The effect of bisphosphonates on osteointegration of the 
dental implant is not clear. Shabestari’s et al. group placed 
46 ITI implants in 21 women with osteoporosis using 
bisphosphonates.[62] No implant movement has been reported, 
and no implant inflammation was seen through the experiments. 
No effect was observed concerning implant location, type of 
prosthesis, front teeth, or time of implant beginning on the 
success of osteointegration. Zahid et al.[63] conducted a study on 
227 patients and reported surgical complications, the number 
of subjects with implants, implant failure, age, sex, smoking, 
body condition, and drugs. Among 51 performed implants 
in 26 patients who are using bisphosphonates, three implant 
failures were seen, and the success rate was 94%. No other 
variable was related with failure or the proposed topics other 
than bisphosphonates.
Radiotherapy
Radiotherapy treatments are mostly administered for head 
and neck cancers. Harmful effects include dry mouth and 
dysfunction of the radiation zone. The new systematic review 
is conducted on irradiation and dental implant by Chambrone 
et al.[64] investigating the number and percentage of the loss 
implants except those only placed in transplanted area. The risk 
of implant failure for implants placed in radiated bones is 174% 
more than non-radiated bones. The risk of implant failure in the 
upper jaw is 496% more than lower jaw implants. To the best of 
author knowledge, there is no sign to approve that hyperbaric 
oxygen therapy influenced the implant failure.
Genetics
Genetic polymorphisms have been studied for evaluating their 
potential role in the implant failure or implant inflammation. 
Those genes, which have been investigated for periodontitis and 
concentration on inflammation and bone cycles, were studies 
in parallel. A new study evaluated IL-1, TNF-α genotypes, and 
titanium implant placement; and reported that the implant 
failure is related significantly to increasing the number of risk 
genotypes of II-1 β and TNF-α.[65]
Combination of the Risk Factors
Although some systematic diseases like cardiovascular diseases 
are not individually considered a risk for the implant failure, 
a combination of the risk factors could cause dental implant 
failure.[66] Extensive researches conducted by Moy et al.,[57] on 
4680 implants in 1140 patients with the same surgery within 
20 years and the potential risk of implant failure has been 
studied. The study carried out linear regression analyses on 
a number of variables and concluded that diabetes, smoking, 
and head and neck radiography are significant predictions in 
the implant failure. More interestingly, they indicated in an 
analysis that implant failure in healthy people is more than 
those who are exposed to the risk. Authors concluded that these 
three variables were no definitive contraindication for implant 
placement. A recent meta-analysis of 51 studies includes more 
than 40000 implants, which evaluating the relationship between 
the implant failure and smoking, radiotherapy, diabetes, and 
osteoporosis.[26] The mentioned study illustrated the positive 
relationship between smoking and radiotherapy and the implant 
failure, but such a result was not obtained for other factors.
Conclusion
In spite of high favorable outcome with endosseous titanium 
implants, some cases of inevitable failure have been occurred, 
as well. Among the most significant causes of implant failure 
in early stages we could name lack of initial stability, surgical 
trauma, surgical-related infection, and occlusal overloading. This 
paper also concentrates on the major factors such as systematic 
diseases, microbiology, periodontitis, smoking, drug treatments 
(especially bisphosphonates), genetic, and a combination of the 
factors. Although results indicated that there are minor cases 
with definitive implant prohibition, smoking, especially in a 
higher level of consumption, is a significant factor in the implant 
failure. Further researches should reveal the combination of 
factors making the patients more vulnerable to peripheral 
mucositis and implant inflammation in that they contributed to 
the implant failure.
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